Oramed Pharmaceuticals
ORMP
#9090
Rank
$0.12 B
Marketcap
$3.04
Share price
4.66%
Change (1 day)
20.92%
Change (1 year)

Oramed Pharmaceuticals (ORMP) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : $8.1 Million USD

According to Oramed Pharmaceuticals's latest financial reports the company's total liabilities are $8.1 Million USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Oramed Pharmaceuticals - Total liabilities on balance sheet (from 2005 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31$9.93 M-82.78%
2023-12-31$57.65 M449.86%
2022-12-31$10.48 M
2021-08-31$11.48 M-2.31%
2020-08-31$11.75 M-23.03%
2019-08-31$15.27 M-6.23%
2018-08-31$16.28 M-16.38%
2017-08-31$19.47 M17.03%
2016-08-31$16.64 M990.43%
2015-08-31$1.52 M51.24%
2014-08-31$1 M90.74%
2013-08-31$0.52 M-65.12%
2012-08-31$1.51 M151.96%
2011-08-31$0.6 M-3%
2010-08-31$0.62 M20.35%
2009-08-31$0.51 M-43.58%
2008-08-31$0.91 M-35.82%
2007-08-31$1.42 M133.86%
2006-08-31$0.6 M1221.76%
2005-08-31$0.04 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Ultragenyx Pharmaceutical
RARE
$1.17 B 14,395.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
$53.83 B 664,499.43%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
$66.02 B 814,948.76%๐Ÿ‡ซ๐Ÿ‡ท France
Compugen
CGEN
$54.01 M 566.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Lexicon Pharmaceuticals
LXRX
$85.76 M 958.73%๐Ÿ‡บ๐Ÿ‡ธ USA